A few months after my husband Todd’s ALS diagnosis, we traveled with our children from our home in southeast Wisconsin to meet up with Todd’s sister and brother-in-law at a rented condo overlooking ...

Enrollment is complete in a Phase 2b trial of PHENOGENE-1A for mild-to-moderate ALS. ALS is a progressive disorder in which motor neurons die, with nervous system inflammation thought to play a role.

The ALS Nexus 2026 conference highlighted cutting-edge research, experimental therapies, and advances in care for ALS.

An emerging body of evidence has hinted that ALS survival may be influenced by exposure to toxins or pollutants in the environment. Specifically, a handful of prior studies have found that ALS ...

To anyone recently diagnosed with ALS, don’t let anyone else write the ending to your story. There is still life to live, ...

Newly diagnosed ALS patients show significantly higher levels of nano- and microplastics in their cerebrospinal fluid and ...

Researchers are testing a device that safely induces a controlled fever as a possible treatment for ALS. The aim is to stimulate the heat-shock response to help nerve cells clear toxic protein clumps ...

A few months ago, my husband and I decided it was time to replace the mattress set we’d slept on for the past 10 years.

A newer set of diagnostic criteria for amyotrophic lateral sclerosis (ALS) was significantly more sensitive at identifying people with the disease than two older diagnostic approaches, a real-world ...

When my late husband, Craig, was diagnosed with ALS, we were very naïve and didn’t really know much about the disease. ALS ...

Neurosense Therapeutics is revamping its development plan for PrimeC, the company’s experimental oral therapy for amyotrophic lateral sclerosis (ALS).

ALN-SOD, an experimental RNA-based therapy being developed for a genetic subtype of amyotrophic lateral sclerosis (ALS) ...